Page 20 - THE SOUTH CHINA BUSINESS JOURNAL
P. 20
C. TODAY
Medical Innovation Happens Across America
By KELLY ANDERSON, U.S. Chamber of Commerce
America is where innovation thrives, and cutting- These are the Americans who have been working
edge medicine is no exception. Right now, tirelessly, defying norms, and exceeding expectations,
scientists are conducting more than 140,000 clinical all in the name of a stronger, healthier future.
trials across all 50 states to explore the potential of
the therapeutics, vaccines, diagnostics, and cures we Now, it’s Congress's turn to do the same. Congress must
need to fight disease—from coronavirus to cancer. focus on common-sense reforms that encourage, inspire and
protect the American innovation sensation, that means:
There’s no question that life-changing, lifesaving
solutions are on the way - as long as we keep the • Not giving away American innovation to
path from mind to market as smooth and obstacle- foreign competitors
free as possible. Because, as the data shows, the
path is already treacherous enough. • Lowering out-of-pocket costs for
medicine without threatening the search for new cures
Today, investing in new drug development requires
between $1.7 billion and $3.2 billion upfront - and • Supporting local innovators who create
there’s little guarantee for success. For every 25,000 good jobs and pioneer new medicines
drug compounds that start in the laboratory, 25 make
it to clinical trials, 5 make it to market, and only one • Promoting America’s leadership in medical
recoups the costs invested. Similarly, new vaccine innovation
projects have an average 94 percent rate of failure.
• Allowing businesses to own the rights to
Considering these realities, it’s a wonder that their discoveries
innovators take up the cause at all. And yet, more
than 800,000 Americans work in the American The pandemic has shown us that by working
biopharmaceutical industry, supporting more than together, we can achieve the unprecedented in
three million additional jobs in related industries, record time. With smart innovation policies in
from construction to transportation to manufacturing. place, we can continue the momentum of progress.
Innovation Spotlight: mRNA Research Happening Now
660 4,932 50 95%
Clinical Trials Clinical Trial Locations States Congressional Districts
One of the most promising tools in our disease-fighting arsenal is messenger RNA or mRNA. While you
may be familiar with mRNA for its use in COVID-19 vaccines, researchers have been studying how to
unleash the power of mRNA for decades to treat a variety of diseases including autoimmune diseases,
respiratory viruses, and cancer.
17 AMCHAM SOUTH CHINA
Medical Innovation Happens Across America
By KELLY ANDERSON, U.S. Chamber of Commerce
America is where innovation thrives, and cutting- These are the Americans who have been working
edge medicine is no exception. Right now, tirelessly, defying norms, and exceeding expectations,
scientists are conducting more than 140,000 clinical all in the name of a stronger, healthier future.
trials across all 50 states to explore the potential of
the therapeutics, vaccines, diagnostics, and cures we Now, it’s Congress's turn to do the same. Congress must
need to fight disease—from coronavirus to cancer. focus on common-sense reforms that encourage, inspire and
protect the American innovation sensation, that means:
There’s no question that life-changing, lifesaving
solutions are on the way - as long as we keep the • Not giving away American innovation to
path from mind to market as smooth and obstacle- foreign competitors
free as possible. Because, as the data shows, the
path is already treacherous enough. • Lowering out-of-pocket costs for
medicine without threatening the search for new cures
Today, investing in new drug development requires
between $1.7 billion and $3.2 billion upfront - and • Supporting local innovators who create
there’s little guarantee for success. For every 25,000 good jobs and pioneer new medicines
drug compounds that start in the laboratory, 25 make
it to clinical trials, 5 make it to market, and only one • Promoting America’s leadership in medical
recoups the costs invested. Similarly, new vaccine innovation
projects have an average 94 percent rate of failure.
• Allowing businesses to own the rights to
Considering these realities, it’s a wonder that their discoveries
innovators take up the cause at all. And yet, more
than 800,000 Americans work in the American The pandemic has shown us that by working
biopharmaceutical industry, supporting more than together, we can achieve the unprecedented in
three million additional jobs in related industries, record time. With smart innovation policies in
from construction to transportation to manufacturing. place, we can continue the momentum of progress.
Innovation Spotlight: mRNA Research Happening Now
660 4,932 50 95%
Clinical Trials Clinical Trial Locations States Congressional Districts
One of the most promising tools in our disease-fighting arsenal is messenger RNA or mRNA. While you
may be familiar with mRNA for its use in COVID-19 vaccines, researchers have been studying how to
unleash the power of mRNA for decades to treat a variety of diseases including autoimmune diseases,
respiratory viruses, and cancer.
17 AMCHAM SOUTH CHINA
